227
Views
1
CrossRef citations to date
0
Altmetric
PHARMACEUTICAL ANALYSIS

HPLC Method for the Determination of the Purity of K[Pt(NH3)Cl3], a Precursor of the Platinum Complexes with Cytostatic Activity

, , , , &
Pages 2182-2193 | Received 05 Jul 2010, Accepted 06 Sep 2010, Published online: 12 Aug 2011
 

Abstract

K[Pt(NH3)Cl3], a valuable precursor for the preparation of platinum complexes with cytostatic activity, e.g. satraplatin, picoplatin, LA-12 and cycloplatam, is currently prepared from cis-[Pt(NH3)2Cl2] or K2[PtCl4] and these are the usual impurities in the final product. A simple, selective and sensitive HPLC-UV analytical method for the determination of the purity of K[Pt(NH3)Cl3] and the quantification of the impurities has been developed and validated. The platinum complexes present in the final product were separated on a strong base ion exchange column by the gradient elution with detection at 213 nm. Intra-assay precisions for the platinum complexes respective to their ions ([PtCl4]2−, [Pt(NH3)Cl3] and cis-[Pt(NH3)2Cl2]) were between 0.1 and 2.0% (relative standard deviation); intermediate precisions were between 1.4 and 2.0% and accuracies were between 98.6 and 101.4%. Limits of detection of [PtCl4]2−, [Pt(NH3)Cl3] and cis-[Pt(NH3)2Cl2] were 6 µg · ml−1, 13 mg · ml−1 and 5 µg · ml−1 respectively, limits of quantification of [PtCl4]2−, [Pt(NH3)Cl3] and cis-[Pt(NH3)2Cl2] were 51 µg · ml−1, 55 mg · ml−1 and 20 µg · ml−1 respectively.

Acknowledgments

We gratefully acknowledge the Ministry of Industry and Trade of the Czech Republic project 2A-2TP1/049 and Grant Agency of the Czech Republic project 203/08/H032-1 for supporting this research financially.

Notes

(a) vs. K[Pt(NH3)Cl3].

Acceptance criteria R 2  > 0.998. (a)x [µg.ml−1].

Acceptance criteria ≤2% for assay ≤2% for assay 98–102% for assay.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.